Melanoma

Tunlametinib: Targeted Breakthrough In Melanoma Therapy

tunlametinib cover

Tunlametinib is a drug used to treat cancer. It is an inhibitor of mitogen-activated protein kinase kinase. In China,tunlametinib was approved in 2024 for the treatment of NRAS mutant advanced melanoma patients who had previously…